Rivastigmine Transdermal System
- Product NDC
- 47781-405
- 11-digit product format
- 477810405
- Labeler code
- 47781
- Product ID
- 47781-405_dd61732f-c277-aa73-22a6-40d65fc71caa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rivastigmine Transdermal System
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Labeler
- Alvogen Inc.
- Application
- ANDA204403
- Marketing category
- ANDA
- Marketing start
- 2015-09-02
- Marketing end
- 0000-00-00
- Substance
- RIVASTIGMINE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 47781-405-03 | 47781040503 | 30 POUCH in 1 CARTON (47781-405-03) > 1 PATCH, EXTENDED RELEASE in 1 POUCH (47781-405-11) | 30 pouch | 2015-09-02 | 0000-00-00 | No | No | Current |